[DPHARMA] QoQ Cumulative Quarter Result on 30-Jun-2012 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
16-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 102.37%
YoY- 5.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 37,837 135,310 99,932 70,412 36,057 138,132 105,096 -49.36%
PBT 8,956 35,298 26,298 17,906 8,869 34,728 26,892 -51.92%
Tax -2,257 -9,284 -6,281 -4,331 -2,161 -8,023 -6,515 -50.64%
NP 6,699 26,014 20,017 13,575 6,708 26,705 20,377 -52.33%
-
NP to SH 6,699 26,014 20,017 13,575 6,708 26,705 20,377 -52.33%
-
Tax Rate 25.20% 26.30% 23.88% 24.19% 24.37% 23.10% 24.23% -
Total Cost 31,138 109,296 79,915 56,837 29,349 111,427 84,719 -48.65%
-
Net Worth 176,143 169,354 167,965 162,400 170,824 163,783 162,405 5.55%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div - 19,434 - 4,858 - 24,983 - -
Div Payout % - 74.71% - 35.79% - 93.56% - -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 176,143 169,354 167,965 162,400 170,824 163,783 162,405 5.55%
NOSH 138,695 138,815 138,814 138,803 138,881 138,799 138,807 -0.05%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 17.70% 19.23% 20.03% 19.28% 18.60% 19.33% 19.39% -
ROE 3.80% 15.36% 11.92% 8.36% 3.93% 16.31% 12.55% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 27.28 97.47 71.99 50.73 25.96 99.52 75.71 -49.33%
EPS 4.83 18.74 14.42 9.78 4.83 19.24 14.68 -52.30%
DPS 0.00 14.00 0.00 3.50 0.00 18.00 0.00 -
NAPS 1.27 1.22 1.21 1.17 1.23 1.18 1.17 5.61%
Adjusted Per Share Value based on latest NOSH - 138,727
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 3.93 14.07 10.39 7.32 3.75 14.36 10.93 -49.40%
EPS 0.70 2.70 2.08 1.41 0.70 2.78 2.12 -52.19%
DPS 0.00 2.02 0.00 0.51 0.00 2.60 0.00 -
NAPS 0.1831 0.1761 0.1746 0.1688 0.1776 0.1703 0.1688 5.56%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 2.23 2.13 2.36 2.23 2.40 2.02 2.10 -
P/RPS 8.17 2.19 3.28 4.40 9.24 2.03 2.77 105.53%
P/EPS 46.17 11.37 16.37 22.80 49.69 10.50 14.31 118.19%
EY 2.17 8.80 6.11 4.39 2.01 9.52 6.99 -54.11%
DY 0.00 6.57 0.00 1.57 0.00 8.91 0.00 -
P/NAPS 1.76 1.75 1.95 1.91 1.95 1.71 1.79 -1.11%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 21/11/11 -
Price 2.51 2.17 2.28 2.38 2.38 2.12 2.10 -
P/RPS 9.20 2.23 3.17 4.69 9.17 2.13 2.77 122.44%
P/EPS 51.97 11.58 15.81 24.34 49.28 11.02 14.31 136.08%
EY 1.92 8.64 6.32 4.11 2.03 9.08 6.99 -57.71%
DY 0.00 6.45 0.00 1.47 0.00 8.49 0.00 -
P/NAPS 1.98 1.78 1.88 2.03 1.93 1.80 1.79 6.95%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment